Abstract
The shortage of available organs for transplantation has led to an increase in the utilization of organs from donors who are dead by cardiac criteria, rather than dead by neurological criteria. The process of salvaging organs from patients who suffered a cardiac arrest from which they could not be resuscitated is an uncontrolled donation after cardiac death (uDCD). This involves placing the donor on extra-corporeal membrane oxygenation (ECMO), to provide circulation for the abdominal organs to be salvaged. In some cases, the flow which the ECMO system can deliver may be too low due to hypovolemia, large volume of distribution, extreme vasodilation, or ongoing fluid loss. We describe a case in which the application of a unique device to exsanguinate the legs and block the return of blood to the legs (arterial tourniquet) led to a substantial increase in ECMO flow, thus improving the perfusion of the abdominal organs.
Introduction
The global shortage of transplantable organs has driven the adoption of uncontrolled Donation After Circulatory Death (uDCD). In these scenarios, patients who suffer an unexpected cardiac arrest and cannot be resuscitated are considered potential donors. To preserve the viability of abdominal organs—primarily the liver and kidneys—clinicians employ Normothermic Regional Perfusion (NRP) using an Extra-Corporeal Membrane Oxygenation (ECMO) system. The goal is to maintain a steady flow of warm, oxygenated blood to the target organs until procurement can occur.
The Challenge of Low ECMO Flow
A critical hurdle in NRP is achieving an optimal flow rate, typically between 2.0 and 3.0 Liters Per Minute (LPM). Donors in uDCD often present with extreme vasodilation, low effective blood volume, or significant fluid loss, all of which impede ECMO performance. While standard practice involves aggressive fluid resuscitation to increase preload, this often leads to organ edema (swelling), which can compromise the quality of the grafts.
The HemaShock Intervention
To address inadequate flow without excessive fluid administration, the authors utilized a novel mechanical solution: the HemaShock device (OHK Medical Devices). This device consists of an elastic silicone ring encased in stockinet fabric designed to be rolled up a limb.
The HemaShock performs two simultaneous functions:
- Exsanguination: It mechanically "squeezes" pooled venous blood from the legs back into the central circulation, acting as a rapid auto-transfusion.
- Tourniquet Action: It blocks arterial inflow to the legs, effectively reducing the total vascular volume the ECMO system must perfuse, thereby concentrating flow to the abdominal core.
In the reported case, this was used alongside an Endovascular Aortic Balloon (EBOA) inflated above the diaphragm to isolate the abdominal circulation.
Clinical Results
The intervention was applied to a 50-year-old male donor at the Sheba Medical Center. Initial ECMO flow was insufficient at 0.8–1.0 LPM. The impact of the HemaShock was immediate and additive:
- Baseline: 0.8–1.0 LPM
- After 1st Leg Application: Flow increased to 1.8 LPM.
- After 2nd Leg Application: Flow reached the target range of 2.8–3.0 LPM.
This mechanical redistribution of blood volume allowed for successful organ procurement. One of the kidneys was subsequently transplanted, showing good post-operative function.
Discussion and Future Directions
This case demonstrates that mechanical exsanguination is a fast and effective way to boost ECMO flow in uDCD donors. By redistributing existing blood volume rather than adding external fluids, clinicians can avoid the risks of organ edema.
While these results are promising, the study is limited by its single-case nature. Further research is needed to validate the safety and efficacy of the HemaShock device across larger donor cohorts and to assess long-term graft outcomes. Nonetheless, this approach offers a simple, rapid, and non-pharmacological tool for improving the success rates of organ salvage in challenging clinical settings.
Summary updated